Caricamento...

A Pilot Pharmacologic Biomarker Study in HLA-Haploidentical Hematopoietic Cell Transplant Recipients

PURPOSE: Eleven patients diagnosed with various hematologic malignancies receiving an HLA-haploidentical hematopoietic cell transplant (HCT) participated in an ancillary biomarker trial. The goal of the trial was to evaluate potential pharmacologic biomarkers pertinent to the conditioning regimen (f...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Bemer, Meagan J., Sorror, Mohamed, Sandmaier, Brenda M., O’Donnell, Paul V., McCune, Jeannine S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3786586/
https://ncbi.nlm.nih.gov/pubmed/23907443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2232-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !